Henigsberg, Neven

Depression symptom dimensions as predictors of antidepressant treatment outcome: replicable evidence for interest-activity symptoms

Uher, R., Perlis, R. H., Henigsberg, N., Zobel, A., Rietschel, M., Mors, O., Hauser, J., Dernovsek, M. Z., Souery, D., Bajs, M., et al. (2012) · Psychological Medicine

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 420

An Inflammatory Biomarker as a Differential Predictor of Outcome of Depression Treatment With Escitalopram and Nortriptyline

Uher, R., Tansey, K. E., Dew, T., Maier, W., Mors, O., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., et al. (2014) · American Journal of Psychiatry

Treatment of Major DepressionTryptophan and brain disorders

Cited by 418

Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression

Köhler-Forsberg, O., Buttenschøn, H. N., Tansey, K. E., Maier, W., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., Farmer, A., Rietschel, M., et al. (2017) · Brain Behavior and Immunity

Tryptophan and brain disordersTreatment of Major Depression

Cited by 283

Genetic predictors of response to antidepressants in the GENDEP project

Uher, R., Huezo-Diaz, P., Perroud, N., Smith, R., Rietschel, M., Mors, O., Hauser, J., Maier, W., Kozel, D., Henigsberg, N., et al. (2009) · The Pharmacogenomics Journal

Treatment of Major DepressionNeurotransmitter Receptor Influence on Behavior

Cited by 226

A Randomized, Double-Blind, Placebo-Controlled 8-Week Trial of the Efficacy and Tolerability of Multiple Doses of Lu AA21004 in Adults With Major Depressive Disorder

Henigsberg, N., Mahableshwarkar, A. R., Jacobsen, P., Chen, Y., & Thase, M. E. (2012) · The Journal of Clinical Psychiatry

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 150

Melancholic, atypical and anxious depression subtypes and outcome of treatment with escitalopram and nortriptyline

Uher, R., Dernovsek, M. Z., Mors, O., Hauser, J., Souery, D., Zobel, A., Maier, W., Henigsberg, N., Kalember, P., Rietschel, M., et al. (2011) · Journal of Affective Disorders

Treatment of Major DepressionAnxiety, Depression, Psychometrics, Treatment, Cognitive Processes

Cited by 112

Neuroimaging research in posttraumatic stress disorder – Focus on amygdala, hippocampus and prefrontal cortex

Henigsberg, N., Kalember, P., Petrović, Z. K., & Šečić, A. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry

Posttraumatic Stress Disorder ResearchTraumatic Brain Injury Research

Cited by 105

Suicidal ideation during treatment of depression with escitalopram and nortriptyline in Genome-Based Therapeutic Drugs for Depression (GENDEP): a clinical trial

Perroud, N., Uher, R., Marusic, A., Rietschel, M., Mors, O., Henigsberg, N., Hauser, J., Maier, W., Souery, D., Placentino, A., et al. (2009) · BMC Medicine

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 57

Non-steroidal anti-inflammatory drugs and efficacy of antidepressants in major depressive disorder

Uher, R., Carver, S., Power, R. A., Mors, O., Maier, W., Rietschel, M., Hauser, J., Dernovsek, M. Z., Henigsberg, N., Souery, D., et al. (2012) · Psychological Medicine

Treatment of Major DepressionTryptophan and brain disorders

Cited by 45

Investigation of blood mRNA biomarkers for suicidality in an independent sample

Mullins, N., Hodgson, K., Tansey, K. E., Perroud, N., Maier, W., Mors, O., Rietschel, M., Hauser, J., Henigsberg, N., Souery, D., et al. (2014) · Translational Psychiatry

Suicide and Self-Harm StudiesTreatment of Major Depression

Cited by 30

Association of refractory complex partial seizures with a polymorphism of ApoE genotype

Sporiš, D., Sertic, J., Henigsberg, N., Mahovic, D., Bogdanovic, N., & Babic, T. (2005) · Journal of Cellular and Molecular Medicine

Epilepsy research and treatmentPharmacological Effects and Toxicity Studies

Cited by 26